Brian A Leuthner
CIK 1652973 · Interim CEO · last filed 2021-06-29
Brian A Leuthner is an Interim CEO who has filed 26 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for ONCS, was dated Jun 29, 2021. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $373.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$373.2K
3
26
-$1.09M
Holdings By Company
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-29 | ONCOSEC MEDICAL Inc (ONCS) Delisted | Mixed | +178,387 | -$43.0K | EDGAR |
| 2021-02-17 | ONCOSEC MEDICAL Inc (ONCS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-18 | PDSB | Exer (M) | +169,032 | $0 | EDGAR |
| 2018-12-28 | EDGE | — | — | $0 | EDGAR |
| 2018-08-15 | EDGE | Grant (A) | — | $0 | EDGAR |
| 2018-06-20 | EDGE | Grant (A) | — | $0 | EDGAR |
| 2018-03-05 | EDGE | Mixed | −5,000 | -$74.7K | EDGAR |
| 2018-02-23 | EDGE | Sell (S) | −5,000 | -$77.1K | EDGAR |
| 2018-02-02 | EDGE | Sell (S) | −5,000 | -$65.2K | EDGAR |
| 2018-01-03 | EDGE | Sell (S) | −5,000 | -$50.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.